JUNIPER PHARMACEUTICALS INC Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
JUNIPER PHARMACEUTICALS INC reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$742.00 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2018-08-09
- JUNIPER PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2012-03-31 was $4.95M.
- JUNIPER PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2011-12-31 was -$1.02M.
- JUNIPER PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2011-09-30 was $4.42M, a 1614.62% increase year-over-year.
- JUNIPER PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2011-06-30 was $18.31M.
- JUNIPER PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2011 was $20.53M.
- JUNIPER PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2010 was -$21.83M.
- JUNIPER PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2009 was -$21.87M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2018-06-30 | -$742.00K 10-Q · filed 2018-08-09 | |||
| 2017-06-30 | -$1.82M 10-Q · filed 2018-08-09 | |||
| 2012-03-31 | $4.95M 10-Q · filed 2012-05-04 | $3.94M derived: sum of 2 quarters · filed 2012-05-04 | $8.35M derived: sum of 3 quarters · filed 2012-05-04 | $26.67M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-12 | $3.40M derived: sum of 2 quarters · filed 2012-03-12 | $21.71M derived: sum of 3 quarters · filed 2012-03-12 | $20.53M 10-K · filed 2012-03-12 |
| 2011-09-30 | $4.42M 10-Q · filed 2011-11-03 | $22.73M derived: sum of 2 quarters · filed 2011-11-03 | $21.54M 10-Q · filed 2011-11-03 | $16.93M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $18.31M 10-Q · filed 2011-08-04 | $17.13M 10-Q · filed 2011-08-04 | $12.51M derived: sum of 3 quarters · filed 2012-05-04 | $12.77M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | -$1.19M 10-Q · filed 2012-05-04 | -$5.80M derived: sum of 2 quarters · filed 2012-05-04 | -$5.54M derived: sum of 3 quarters · filed 2012-05-04 | -$9.77M derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | -$4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-12 | -$4.36M derived: sum of 2 quarters · filed 2012-03-12 | -$8.59M derived: sum of 3 quarters · filed 2012-03-12 | -$21.83M 10-K · filed 2012-03-12 |
| 2010-09-30 | $257.62K 10-Q · filed 2011-11-03 | -$3.97M derived: sum of 2 quarters · filed 2011-11-03 | -$17.22M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | -$4.23M 10-Q · filed 2011-08-04 | -$17.47M 10-Q · filed 2011-08-04 | ||
| 2009-12-31 | -$21.87M 10-K · filed 2012-03-12 |